Zoran Zdraveski, J.D., Ph.D.
Chief Legal and Strategy Officer
“It’s exciting to work alongside the TScan team as we advance our mission of creating life-changing T cell therapies for patients, harnessing the full potential of our platform technology.”
Zoran Zdraveski, J.D., Ph.D., is the Chief Legal and Strategy Officer at TScan Therapeutics. He has more than 20 years of legal, IP and business operations experience in the biopharmaceutical industry. Prior to joining TScan, Zoran served as the Chief Legal and Technology Operations Officer at Magenta Therapeutics Inc., where he established the legal team and managed all aspects of legal, intellectual property and compliance both before and after the company’s 2018 initial public offering. Prior to Magenta, he was the Vice President and Associate General Counsel at Epizyme Inc. Prior to joining Epizyme, he held patent counsel positions at Ironwood and Genzyme Therapeutics. Zoran holds an M.S. in Chemistry and a B.F.A. and B.A. in Art and Chemistry from Southern Methodist University, a J.D. from Suffolk University Law School, and a Ph.D. in Biochemistry from the Massachusetts Institute of Technology.
When not at TScan, Zoran enjoys traveling, motorcycle riding, and creating and exhibiting fine art.